These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 35884552)

  • 1. N
    Chen D; Cheung H; Lau HC; Yu J; Wong CC
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N6-Methyladenosine Reader YTHDF1 Promotes ARHGEF2 Translation and RhoA Signaling in Colorectal Cancer.
    Wang S; Gao S; Zeng Y; Zhu L; Mo Y; Wong CC; Bao Y; Su P; Zhai J; Wang L; Soares F; Xu X; Chen H; Hezaveh K; Ci X; He A; McGaha T; O'Brien C; Rottapel R; Kang W; Wu J; Zheng G; Cai Z; Yu J; He HH
    Gastroenterology; 2022 Apr; 162(4):1183-1196. PubMed ID: 34968454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The m
    Chen XY; Liang R; Yi YC; Fan HN; Chen M; Zhang J; Zhu JS
    Front Cell Dev Biol; 2021; 9():647702. PubMed ID: 33791305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YTHDF1 Aggravates the Progression of Cervical Cancer Through m
    Wang H; Luo Q; Kang J; Wei Q; Yang Y; Yang D; Liu X; Liu T; Yi P
    Front Oncol; 2021; 11():650383. PubMed ID: 33816306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YTHDF1 promotes intrahepatic cholangiocarcinoma progression via regulating EGFR mRNA translation.
    Huang X; Zhu L; Wang L; Huang W; Tan L; Liu H; Huo J; Su T; Zhang M; Kuang M; Li X; Dai Z; Xu L
    J Gastroenterol Hepatol; 2022 Jun; 37(6):1156-1168. PubMed ID: 35233828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis.
    Wang L; Zhu L; Liang C; Huang X; Liu Z; Huo J; Zhang Y; Zhang Y; Chen L; Xu H; Li X; Xu L; Kuang M; Wong CC; Yu J
    J Hepatol; 2023 Nov; 79(5):1185-1200. PubMed ID: 37459919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YTHDF1 Promotes Gastric Carcinogenesis by Controlling Translation of
    Pi J; Wang W; Ji M; Wang X; Wei X; Jin J; Liu T; Qiang J; Qi Z; Li F; Liu Y; Ma Y; Si Y; Huo Y; Gao Y; Chen Y; Dong L; Su R; Chen J; Rao S; Yi P; Yu S; Wang F; Yu J
    Cancer Res; 2021 May; 81(10):2651-2665. PubMed ID: 32788173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The m
    Diao H; Tan H; Hu Y; Wang R; Cai P; Huang B; Shao X; Yan M; Yin C; Zhang Y
    Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YTHDF1-enhanced iron metabolism depends on TFRC m
    Ye J; Wang Z; Chen X; Jiang X; Dong Z; Hu S; Li W; Liu Y; Liao B; Han W; Shen J; Xiao M
    Theranostics; 2020; 10(26):12072-12089. PubMed ID: 33204330
    [No Abstract]   [Full Text] [Related]  

  • 10. YTHDF1 facilitates esophageal cancer progression via augmenting m6A-dependent TINAGL1 translation.
    Zhang L; Cai E; Xu Y; Liu Z; Zheng M; Sun Z; Pei D; Wang Q
    Cell Signal; 2024 Oct; 122():111332. PubMed ID: 39098703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. m
    You Q; Wang F; Du R; Pi J; Wang H; Huo Y; Liu J; Wang C; Yu J; Yang Y; Zhu L
    Adv Mater; 2023 Feb; 35(8):e2204910. PubMed ID: 36484103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RUVBL1/2 Blockade Targets YTHDF1 Activity to Suppress m6A-Dependent Oncogenic Translation and Colorectal Tumorigenesis.
    Chen D; Ji F; Zhou Q; Cheung H; Pan Y; Lau HC; Liang C; Yang Z; Huang P; Wei Q; Cheung AH; Kang W; Chen H; Yu J; Wong CC
    Cancer Res; 2024 Sep; 84(17):2856-2872. PubMed ID: 38900944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ELK1-mediated YTHDF1 drives prostate cancer progression by facilitating the translation of Polo-like kinase 1 in an m6A dependent manner.
    Li P; Shi Y; Gao D; Xu H; Zou Y; Wang Z; Li W
    Int J Biol Sci; 2022; 18(16):6145-6162. PubMed ID: 36439881
    [No Abstract]   [Full Text] [Related]  

  • 14. The roles and mechanisms of the m6A reader protein YTHDF1 in tumor biology and human diseases.
    Chen Z; Zhong X; Xia M; Zhong J
    Mol Ther Nucleic Acids; 2021 Dec; 26():1270-1279. PubMed ID: 34853726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insufficient Radiofrequency Ablation Promotes Hepatocellular Carcinoma Metastasis Through N6-Methyladenosine mRNA Methylation-Dependent Mechanism.
    Su T; Huang M; Liao J; Lin S; Yu P; Yang J; Cai Y; Zhu S; Xu L; Peng Z; Peng S; Chen S; Kuang M
    Hepatology; 2021 Sep; 74(3):1339-1356. PubMed ID: 33638162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation.
    Liu T; Wei Q; Jin J; Luo Q; Liu Y; Yang Y; Cheng C; Li L; Pi J; Si Y; Xiao H; Li L; Rao S; Wang F; Yu J; Yu J; Zou D; Yi P
    Nucleic Acids Res; 2020 Apr; 48(7):3816-3831. PubMed ID: 31996915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The function and clinical implication of YTHDF1 in the human system development and cancer.
    Ren W; Yuan Y; Li Y; Mutti L; Peng J; Jiang X
    Biomark Res; 2023 Jan; 11(1):5. PubMed ID: 36650570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The m6A readers
    Anita R; Paramasivam A; Priyadharsini JV; Chitra S
    Am J Cancer Res; 2020; 10(8):2546-2554. PubMed ID: 32905518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.
    Li Q; Ni Y; Zhang L; Jiang R; Xu J; Yang H; Hu Y; Qiu J; Pu L; Tang J; Wang X
    Signal Transduct Target Ther; 2021 Feb; 6(1):76. PubMed ID: 33619246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N
    Wang J; Wang L; Tian X; Luo L
    PeerJ; 2023; 11():e14951. PubMed ID: 36992945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.